Drug intelligence / Profile preview

cefmetazole

Development stage
Phase 4
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Cefmetazole is a semisynthetic cephamycin antibiotic, usually grouped with the second-generation cephalosporins. It exhibits a broad spectrum of activity against both gram-positive and gram-negative bacteria, including anaerobes such as Bacteroides fragilis. Cefmetazole is particularly effective against beta-lactamase-producing organisms that are resistant to first-generation cephalosporins or penicillins. Its mechanism of action involves inhibition of bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. The drug is administered parenterally (intravenous or intramuscular) and is used for treating respiratory tract, skin and soft tissue, urinary tract, gynecologic infections, as well as for perioperative prophylaxis in certain surgical procedures[1][2][4].

Brand names
Zefazone
Other names
cefmetazole sodium
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefmetazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefmetazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call